Deoxypheganomycin D
Product Specifications
UNSPSC Description
Deoxypheganomycin D is a specific antimycobacterial inhibitor with no cross-resistance to other antibiotics such as Paromomycin (HY-B0956), Capreomycin (HY-P3270), Viomycin (HY-A0155), Streptothricin (HY-129065), Kanamycin (HY-16566), and Streptomycin (HY-B1906). Deoxypheganomycin D (28 μM) partially inhibits the growth of Mycobacterium 607, with no significant inhibitory effects on DNA, RNA, or protein synthesis. Deoxypheganomycin D (7 μM) affects leucine influx, not thymidine, and has the opposite effect on efflux. The effects of Deoxypheganomycin D may be related to cell membrane and specific mycobacterial lipid components.
Target Antigen
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/deoxypheganomycin-d.html
Smiles
OC(C[C@@H](C(O)=O)NC([C@H](CCCCN)NC([C@H](C(C)(C)C)NC([C@H](CC(N)=O)NC([C@H](C1=CC(O)=C(C(O)=C1)C)NC(N)=N)=O)=O)=O)=O)=O
Molecular Weight
709.75
References & Citations
[1]Suzukake-Tsuchiya K, et al. Mode of action of deoxypheganomycin D on Mycobacterium smegmatis ATCC 607. J Antibiot (Tokyo). 1988 May;41(5):675-83.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-129262/Deoxypheganomycin-D-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-129262/
Clinical Information
No Development Reported
CAS Number
69280-94-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DAG581 100ug
Recombinant Treponema Pallidum, Treponemal Membrane Protein A (N-terminal)
Ask
View Details 
